Cancer cells overexpressing PD‐L1 will cause T cell exhaustion and thus an immunosuppressive tumor microenvironment, resulting in a low response rate to immunotherapy.[34] Chemotherapy is always accompanied by PD‐L1 overexpression in tumor cells. This evidence concerns the gene CD274 and neoplasm.